Evaluation of cyclic AMP accumulation in EBV-transformed human B-lymphocytes: Effects of dopamine agonists, isoproterenol, prostaglandin E1, cholera toxin, forskolin, and phorbol 12-myristate-13 acetate

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 1, 1996, Pages 99-108

  Natsukari, Naoki ^a   Kulaga, Henrietta ^a   Baker, Ivory ^a   Wyatt, Richard Jed ^a   Masserano, Joseph M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cyclic AMP; Dopamine; Protein kinase C; Transformed human lymphocytes

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CHOLERA TOXIN; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FORSKOLIN; ISOPRENALINE; PHORBOL ESTER; PROSTAGLANDIN E1; QUINPIROLE;

ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL TRANSFORMATION; HUMAN; HUMAN CELL; RECEPTOR BINDING;

ALPROSTADIL; B-LYMPHOCYTES; CHOLERA TOXIN; CYCLIC AMP; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HUMANS; ISOPROTERENOL; PHORBOL ESTERS;

EID: 0029922901     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(95)00295-2     Document Type: Article

References (31)

1. BELL, J. D. AND BRUNTON, L. L. (1987). Multiple effects of phorbol esters on hormone-sensitive adenylate cyclase activity in S49 lymphoma cells. Am. J. of Physiol 252: E783-E789.
2. BONDY, B., RUPPERT, T. AND ACKENHEIL, M. (1990). Spiperon-Bindung an Lymphozyten: Bestandteil eines Dopamin-Aufnamesystems. Fortschrung des Neurologischen Psychiatrie 58: 25.
3. 3H-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia. J. of Psych. Res. 21: 521-529.
4. COCCINI, T., MANZO, L. AND COSTA, L. G. (1991). 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes. Immunopharmacol. 22: 93-106.
5. COOPER, D. M. F., BIER-LANING, C. M., HALFORD, M. K., AHLIJANIAN, M. K. AND ZAHNISER, N. R. (1986). Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process. Mol. Pharmacol. 29: 113-119.
6. FEENSTRA, A., COGGIANO, M. A. AND WYATT, R. J. (1989). Binding of 3H-spiperone to human peripheral lymphocytes: absence of stereospecific high-affinity binding. Psych. Res. 30: 259-264.
7. 3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and nonresponsive schizophrenic patients. Biol. Psych. 27: 1327-1330.
8. HUDSON, C. J., TREVOR, Y., LI, P. P. AND WARSH, J. J. (1993). CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13: 278-293.
9. KASSIS, S., ZAREMBA, T., PATEL, J. AND FISHMAN, P . H. (1985). Phorbol esters and β-adrenergic agonists mediate desensitization of adenylate cyclase in rat glioma C6 cells by distinct mechanisms. J. Biol. Chem. 260: 8911-8917.
10. KATADA, T., KUSAKABE, K., OINUMA, M. AND UI, M. (1987). A novel mechanisms for the inhibition of adenylate cyclase via inhibitory GTP-binding proteins, calmodulin-dependent inhibition of the cyclase catalyst by the beta gamma-subunits of GTP-binding proteins. J. Biol. Chem. 262: 11897-11900.
11. KLEE, C. B., CROUGH, T. J. AND RICHMAN, P. G. (1980). Calmodulin. Ann. Rev. Biochem. 49: 489-515.
12. KOUASSI, E. AND REVILLARD, J. -P. (1987). Contribution of β-adrenoceptors to the dopamine-induced elevation of cyclic 3′,5′-adenosine monophosphate levels in mouse lymphocytes. European J. Pharmacol. 144: 97-100.
13. LEFUR, G., ZARIFIAN, E., PHAN, T., CUCHE, H., FLAMIER, A., BOUCHAMI, F., BURGEVIN, M. C., LOO, H., GERARD, A. AND UZAN, A. (1983). 3H-spiperone binding in lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment. Life Sci. 32: 249-255.
14. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J. (1951). Protein measurement with the Folin phenol reagent. J. of Biol. Chem. 193: 265-275.
15. MANGEL, L. A. AND GNEGY, M. E. (1992). Cyclic AMP accumulation alters calmodulin localization in SK-N-SH human neuroblastoma cells. Mol. Brain Res. 12: 103-110.
16. MOYERS, J. S., BOUTON, A. H. AND PARSONS, S. J. (1993). The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to β-adrenergic agonists in cells overexpressing c-src. Mol. and Cell. Biol. 13: 2391-2400.
17. MURAYAMA, T., NOMURA, Y. AND UI, M. (1989). Enhancement of adenosine A2 and prostaglandin E1 receptor-mediated CAMP generation by prior exposure of Swiss 3T3 fibroblast to Ca-mobilizing receptor agonists or phorbol ester. J. Biol. Chem. 264: 15186-15191.
18. NAGAI, Y., SAEKI, Y. AND UENO, S. (1993). Expression of dopamine D3, D5 receptors and the transcription of a new D3 isotype gene in human lymphocytes. Bull. Japanese Neurochem. Soc. 32: 76-77.
19. NATSUKARI, N., HANAI, H., MATSUNAGA, T. AND FUJITA, M. (1990). Synergistic activation of brain adenylate cyclase by calmodulin, and either GTP or catecholamines including dopamine. Brain Res. 534: 170-176.
20. NATSUKARI, N., MIWA, A. AND FUJITA, M. (1992). Calmodulin-binding proteins of calcium-independent type in rat brain synaptosomal membranes: their localization and properties. Biochem. Biophysical Res. Comm. 183: 725-732.
21. O'DOWD, B. F. (1993). Structures of dopamine receptors. J. Neurochem. 60: 804-816.
22. OVADIA, H. AND ABRAMSKY, O. (1987). Dopamine receptors on isolated membranes of rat lymphocytes. J. Neurosci. Res. 18: 70-74.
23. PETERSON, G. L. (1977) . A simplification of the protein assay method of the Lowry at al. which is more generally applicable. Anal. Biochem. 83: 346-356.
24. RAO, M. L., DEISTER, A. AND ROTH, A. (1990). Lymphocytes of healthy subjects and schizophrenic patients possess no high-affinity binding sites for spiroperidol. Pharmacopsych. 23: 176-181.
25. SAWAI, T., NEGISHI, M., NISHIGAKI, N., OHNO, T. AND ICHIKAWA, A. (1993). Enhancement by protein kinase C of prostacyclin receptor-mediated activation of adenylate cyclase through a calmodulin/myristoylated alanine-rich C kinase substrate (MARCKS) system in IC2 mast cells. J. Biol. Chem. 268: 1995-2000.
26. SEEMAN, P. (1992). Dopamine receptor sequences. Therapeutic levels of neuroleptics occupying D2 receptors, clozapine occupies D4. Neuropsychopharmacol. 7: 261-284.
27. SHASKAN, E. G., BALLOW, M., LEDERMAN, M., MARGOLES, S. L. AND MELCHREIT, R. (1984). Spiroperidol binding sites on mouse lymphoid cells. Effects of ascorbic acid and psychotropic drugs. J. Neuroimmunol. 6: 59-66.
28. STEPIEN, H., KUNERT-RADEK, J., KARASEK, E. AND PAWLIKOWSKI, M. (1981). Dopamine increases cyclic AMP concentration in the rat spleen lymphocytes in vitro. Biochem. Biophy. Res. Comm. 101: 1057-1063.
29. TAKAHASHI, N., NAGAI, Y., UENO, S., SAEKI, Y. AND YANAGIHARA, T. (1992). Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudogenes. FEBS Letters 314: 23-25.
30. WODARZ, N., FRITZE, J., KORNHUBER, J. AND RIEDERER, P. (1992). 3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspects. Biol. Psych. 31: 291-303.
31. YOSHIMASA, T., SIBLEY, D. R., BOUVIER, M., LEFKOWITZ, R. J. AND CARON, G (1987). Cross-talk between cellular signalling pathways suggested by phorbol ester induced adenylate cyclase phosphorylation. Nature 327: 67-70.